About: Immunogenicity of anti-Haemophilus influenzae type b CRM197 conjugate following mucosal vaccination with oligodeoxynucleotide containing immunostimulatory sequences as adjuvant

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Immunogenicity of anti-Haemophilus influenzae type b CRM197 conjugate following mucosal vaccination with oligodeoxynucleotide containing immunostimulatory sequences as adjuvant Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 2002

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2002 (uk) article scientifique publié en 2002 (fr) im Mai 2002 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 2002 (ast) գիտական հոդված հրատարակված 2002 թվականի մայիսի 1-ին (hy) scientific article published on 01 May 2002 (en)
publication date	wds:Q74092627-66346B45-DE81-4011-90D1-C435FB62F867
publication date	2002-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q74092627-B14350D8-8E43-415F-80AC-CFA7032BF91C
language of work or name	English
cites work	wds:Q74092627-05E75E6C-A05C-4C01-98DF-C15032E00064 wds:Q74092627-0DAE1599-4357-4D0B-B277-837E969C1D20 wds:Q74092627-1023639D-8412-4236-AF12-243904AD151C wds:Q74092627-218FDE1B-443B-42D5-A19E-0412D893E104 wds:Q74092627-23A9696A-0E2B-4D66-86F0-09536872EDC3 wds:Q74092627-23DDC0CB-D78A-4A16-8A9F-F22B1F912466 wds:Q74092627-28AD55FA-E426-4144-AB41-B91E802888F0 wds:Q74092627-2BD2B0DD-5C78-4251-8E91-A4EA978E7995 wds:Q74092627-2E849338-AD6C-4641-A32F-42C089EFC404 wds:Q74092627-3EE8C9EB-4B50-4B8A-80AF-87DDC27129C5 wds:Q74092627-463E6A4A-6370-41A0-8817-4FBD764800A2 wds:Q74092627-46DAA66E-DEFC-459D-9569-6C5F191AF2CC wds:Q74092627-5124E1A4-30D8-47F9-9487-CE51DD6413C3 wds:Q74092627-51C08F88-E219-4931-B816-73D647233E1F wds:Q74092627-5A3D8A63-1509-4B97-8733-4A503AE25D2A wds:Q74092627-61EFB86F-D3E9-46CC-A4F5-7721F1B4CF48 wds:Q74092627-697DD5BB-5602-4431-84D0-31E057D834E0 wds:Q74092627-72C83A60-2CFA-4445-8C2B-4A188B2B1D71 wds:Q74092627-74364745-42AA-40EB-883A-A335C7D185CD wds:Q74092627-75734324-238F-484F-A166-40908D43D2E4 wds:Q74092627-85AA8E3C-27C4-42BB-BA9A-8EEA619EF9D1 wds:Q74092627-908082FA-D683-49B9-87B8-3762EA318522 wds:Q74092627-93C7C1F0-79D7-47B3-8F13-B1C35B9C5769 wds:Q74092627-A203ECFE-B19E-4697-B0A8-A6819A0E556B wds:Q74092627-A218E83C-4D32-4419-92ED-C92B133D1694 wds:Q74092627-A5F4906F-338D-4BBD-B245-8B11B5E1417A wds:Q74092627-BC75E18E-016D-40A6-9EEB-3ABE9BEDCBF2 wds:Q74092627-C4220DC5-85FA-4268-AC52-EBF9C0BBBD8C wds:Q74092627-CE83957C-7EB2-4B5C-975C-608A1C64088F wds:Q74092627-D56CEA48-B3A8-43D7-AC48-FA9CF4D19C77 wds:Q74092627-E2F6C960-2FCB-4E9F-BD05-87D209EF5ED5 wds:Q74092627-EADB4797-B710-4C6C-8D65-207E4880AFEB wds:Q74092627-F0D7AB9F-CB79-44ED-BDE0-2B4F1A477A89 wds:Q74092627-F42BA719-5EA0-4BB5-B0DF-0E99FBF1342E wds:Q74092627-FB253830-3BF6-4995-8031-DC37CA84F3D1 wds:Q74092627-FF921C18-D0F7-43C2-9B19-9E2E1212E4ED
cites work	Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Lymphokine control of in vivo immunoglobulin isotype selection. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo Immunostimulatory sequence oligodeoxynucleotide: A novel mucosal adjuvant DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates The epidemiology and prevention of disease caused by Haemophilus influenzae type b. Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma Immune activation by bacterial DNA: a new genetic code Passively acquired anti-tetanus and anti-Haemophilus antibodies and the response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infancy CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming Immunostimulatory DNA is a potent mucosal adjuvant Synthetic oligodeoxynucleotide containing CpG motif induces an anti-polysaccharide type 1-like immune response after immunization of mice with Haemophilus influenzae type b conjugate vaccine CpG motifs as immune adjuvants Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen Immunostimulatory CpG motifs trigger a T helper-1 immune response to human immunodeficiency virus type-1 (HIV-1) gp 160 envelope proteins A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery Interaction of Haemophilus influenzae type b conjugate vaccines with diphtheria-tetanus-pertussis vaccine in control tests The adjuvant effect of synthetic oligodeoxynucleotide containing CpG motif converts the anti-Haemophilus influenzae type b glycoconjugates into efficient anti-polysaccharide and anti-carrier polyvalent vaccines Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines Neutralization of diphtheria toxin by human immunoglobulin classes and subunits CpG DNA as mucosal adjuvant Immuno-stimulatory effects of bacterial-derived plasmids depend on the nature of the antigen in intramuscular DNA inoculations Serum antibodies against haemophilus influenzae type b and tetanus at 2.5 years of age: a follow-up of 2 different regimens of infant vaccination Differences in the immunogenicity of native and formalinized cross reacting material (CRM197) of diphtheria toxin in mice and guinea pigs and their implications on the development and control of diphtheria vaccine based on CRMs. The effect of conjugation on immunogenicity and potency of protein carriers of polyribosylribitol phosphate (PRP) conjugated vaccines in the mouse model. Cholera toxin and related enterotoxins as potent immune modulators
author name string	wds:Q74092627-3C3B0F41-0492-4E16-B403-6D3C3727D55F wds:Q74092627-98629A2F-7D81-4214-B7C8-3619404D3B57 wds:Q74092627-9A4C36BE-BE78-4340-84D2-40180D302F2A wds:Q74092627-CC4F0A33-0A9E-44D8-A825-0E0F7371B695
author name string	Graziella Orefici Raffaela Teloni Giulia Romagnoli Christina von Hunolstein
rdfs:label	Immunogenicity of anti-Haemophilus influenzae type b CRM197 conjugate following mucosal vaccination with oligodeoxynucleotide containing immunostimulatory sequences as adjuvant (en) Immunogenicity of anti-Haemophilus influenzae type b CRM197 conjugate following mucosal vaccination with oligodeoxynucleotide containing immunostimulatory sequences as adjuvant (nl)
skos:prefLabel	Immunogenicity of anti-Haemophilus influenzae type b CRM197 conjugate following mucosal vaccination with oligodeoxynucleotide containing immunostimulatory sequences as adjuvant (en) Immunogenicity of anti-Haemophilus influenzae type b CRM197 conjugate following mucosal vaccination with oligodeoxynucleotide containing immunostimulatory sequences as adjuvant (nl)
name	Immunogenicity of anti-Haemophilus influenzae type b CRM197 conjugate following mucosal vaccination with oligodeoxynucleotide containing immunostimulatory sequences as adjuvant (en) Immunogenicity of anti-Haemophilus influenzae type b CRM197 conjugate following mucosal vaccination with oligodeoxynucleotide containing immunostimulatory sequences as adjuvant (nl)
author	wds:Q74092627-10160643-DCAA-4732-B597-F22F24CDDCAF wds:Q74092627-5E45DA6A-E4AE-4640-8925-B95900643DAC

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software